OncoMed Pharmaceuticals Inc Increase (Decrease) in Contract with Customer, Liability
OncoMed Pharmaceuticals Inc reported Increase (Decrease) in Contract with Customer, Liability of -$44.42 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2019-03-07
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for the quarter ending 2018-12-31 was -$10.18M.
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for the quarter ending 2018-09-30 was -$19.52M.
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for the quarter ending 2017-12-31 was -$20.55M.
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for the quarter ending 2017-09-30 was -$5.01M.
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for fiscal 2018 was -$44.42M.
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for fiscal 2017 was -$36.05M.
- OncoMed Pharmaceuticals Inc increase (decrease) in contract with customer, liability for fiscal 2016 was -$21.27M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$29.70M derived: sum of 2 quarters · filed 2019-03-07 | -$44.42M 10-K · filed 2019-03-07 | |
| 2018-09-30 | -$19.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$34.24M 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | -$14.72M 10-Q · filed 2018-08-02 | |||
| 2017-12-31 | -$20.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$25.56M derived: sum of 2 quarters · filed 2019-03-07 | -$36.05M 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$5.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$15.50M 10-Q · filed 2018-11-01 | ||
| 2017-06-30 | -$10.48M 10-Q · filed 2018-08-02 | |||
| 2016-12-31 | -$21.27M 10-K · filed 2019-03-07 |